NDC 0404-9901

LINCOMYCIN

Lincomycin Hydrochloride

LINCOMYCIN is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Henry Schein, Inc.. The primary component is Lincomycin Hydrochloride.

Product ID0404-9901_a4717ef4-6cd1-4b65-83db-28c8a55ed672
NDC0404-9901
Product TypeHuman Prescription Drug
Proprietary NameLINCOMYCIN
Generic NameLincomycin Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
Marketing Start Date2022-01-12
Marketing CategoryANDA /
Application NumberANDA201746
Labeler NameHenry Schein, Inc.
Substance NameLINCOMYCIN HYDROCHLORIDE
Active Ingredient Strength300 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0404-9901-10

1 VIAL in 1 BAG (0404-9901-10) > 10 mL in 1 VIAL
Marketing Start Date2022-01-12
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LINCOMYCIN" or generic name "Lincomycin Hydrochloride"

NDCBrand NameGeneric Name
0404-9901LINCOMYCINlincomycin hydrochloride
39822-0350Lincomycinlincomycin hydrochloride
39822-0353Lincomycinlincomycin hydrochloride
50090-4533Lincomycinlincomycin hydrochloride
52584-353LINCOMYCINlincomycin hydrochloride
70625-113Lincomycinlincomycin
0009-0555Lincocinlincomycin hydrochloride

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.